Seizure and Interictal Electroencephalographic (EEG) Changes with Cannabinoid Concentrate Use.
Journal
The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566
Informations de publication
Date de publication:
18 Apr 2021
18 Apr 2021
Historique:
entrez:
18
4
2021
pubmed:
19
4
2021
medline:
22
4
2021
Statut:
epublish
Résumé
BACKGROUND The electroencephalographic (EEG) findings associated with tetrahydrocannabinol (THC) use, particularly in concentrated form, are not well-described, despite the current widespread availability of these products. There is a lack of prior research describing the EEG findings in adolescent cannabis users, and the effects of THC on the seizure threshold have been variably reported. CASE REPORT A 17-year-old girl with no prior history of seizures or known seizure risk factors presented to an Emergency Department with acutely abnormal behavior in the setting of daily vaping of highly concentrated THC marijuana ("wax"). On admission, she had a witnessed generalized tonic-clonic seizure. Urine toxicology was positive for THC, and an extensive evaluation for other etiologies of her encephalopathy was unrevealing. Extended EEG on admission showed mild diffuse background slowing with occasional bifronto-centrally predominant sharp and spike wave discharges. Seven days later, without interim antiseizure medications, a repeat extended EEG showed resolution of the previously seen interictal findings. CONCLUSIONS The clinical and EEG findings were temporally associated with the patient's use of concentrated THC and may represent a constellation of symptoms of a THC wax toxidrome. In this case, THC was associated with lowering the seizure threshold and triggering a provoked seizure in an adolescent with no prior evidence of seizure tendency. This case also suggests the possibility of THC concentrate itself generating epileptiform discharges, as has previously been described with synthetic cannabinoid use.
Identifiants
pubmed: 33866321
pii: 931360
doi: 10.12659/AJCR.931360
pmc: PMC8063765
doi:
Substances chimiques
Cannabinoids
0
Dronabinol
7J8897W37S
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e931360Références
Drugs Today (Barc). 2003 Jul;39(7):551-7
pubmed: 12973403
Curr Pharm Des. 2014;20(13):2186-93
pubmed: 23829363
Epilepsia. 2001 Oct;42(10):1266-72
pubmed: 11737161
Behav Neurosci. 2009 Aug;123(4):894-904
pubmed: 19634950
Yakugaku Zasshi. 2019;139(5):693-697
pubmed: 31061337
Neuropsychopharmacology. 2013 Nov;38(12):2338-47
pubmed: 23822952
Biol Psychiatry. 2016 Apr 1;79(7):568-77
pubmed: 26850792
Nat Rev Neurosci. 2015 May;16(5):264-77
pubmed: 25891509
Epilepsy Behav. 2020 Mar;104(Pt A):106901
pubmed: 31958643
Neurohospitalist. 2011 Oct;1(4):182-6
pubmed: 23983854